Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > QuantuMDx Group Receives Exclusive Licenses from Nanosys for Advanced Materials to Improve Next Generation Diagnostic and Sequencing Technologies

Abstract:
QuantuMDx Group Limited, a handheld diagnostics and sequencing company, today announced that it has signed an exclusive license agreement with Nanosys Inc., an advanced materials architect, for several patents and patent applications related to the use of nanostructures for biosensors.

QuantuMDx Group Receives Exclusive Licenses from Nanosys for Advanced Materials to Improve Next Generation Diagnostic and Sequencing Technologies

Newcastle, UK | Posted on October 13th, 2011

The core intellectual property involves the use of nanowires and nanotubes in biosensors, including field effect transistors (FETs) biosensors, which were derived from the work of Prof. Charles Lieber, a professor of chemistry at Harvard and pioneer in nanotechnology.

Under terms of the agreement, QuantuMDx has secured exclusive worldwide rights for the use of nanostructures for DNA sequencing and, amongst others, detecting nucleic acid biomarkers associated with disease. In exchange, Nanosys has received an upfront license fee and downstream royalty payments. No other financial details of the deal were disclosed.

Nanosys owns an extensive IP portfolio around multiple aspects of nanotechnology including quantum dots and nanowires for diverse applications, with a primary focus on LED backlighting and energy storage. QuantuMDx Group will use the exclusive access to these nanowire composition, synthesis and use patents, along with its proprietary molecular biology, chemistry and microfluidic technologies in a series of portable devices for molecular diagnostics and DNA Sequencing.

"The power of Nanosys's technology is that it enables accurate diagnosis and quantification of multiple biomarkers using small arrays of biosensors that readily lends itself to our ‘DNA sequencing while you wait' diagnostic devices, with numerous medical, veterinary and military applications" said Elaine Warburton, chief executive officer of QuantuMDx Group.

QuantuMDx Group's medical director, Professor Sir John Burn, went on to say "We are creating a simple to use, sample to result device which will provide robust, handheld, clinical DNA sequencing at the point of care. The technology is cheap by any measure and with turnaround times in the minutes, it will be an exciting and significant new instrument in the clinical tool box. I believe it will facilitate the wider uptake of DNA sequencing by the medical fraternity."

Andrew Filler, general counsel and vice president of intellectual property at Nanosys, commented, "Through continued development, licensing and commercialization such as we have done with QuantuMDx, Nanosys is expanding the transformative applications of advanced materials in the marketplace."

####

About QuantuMDx Group Limited
QuantuMDx Group is a U.K. based nanomedtech company founded by Elaine Warburton, an experienced healthcare chief executive and Jonathan O’Halloran, a molecular biologist and the inventor of QuantuMDx Group’s technology. QuantuMDx Group is developing and commercializing affordable handheld sample-to-result diagnostic and genomic sequencing technologies based around a nanowire biosensor and innovative microfluidics. The company has offices in the U.K. and U.S.A.. Additional information on QuantuMDx Group can be found at www.quantumdx.com

About Nanosys, Inc.

Nanosys, Inc. is an advanced material architect, harnessing the fundamental properties of inorganic materials into process ready systems that can integrate into existing manufacturing to produce vastly superior products in lighting, electronic displays and energy storage. Based in Palo Alto, Nanosys has built one of the broadest technology platforms in the industry with over 750 patents and patent applications covering fundamental areas of nanotechnology. Additional information on Nanosys can be found at www.nanosysinc.com.

For more information, please click here

Contacts:
International Centre for Life

Times Square

Newcastle-upon-Tyn e

Tyne and Wear

NE1 4EP
Tel: +44 870 803 1234

Fax: +44 870 803 0999

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Drilling speed increased by 20% – yet another upgrade in the oil & gas sector made possible by graphene nanotubes January 15th, 2019

Chirality in 'real-time' January 14th, 2019

New materials could help improve the performance of perovskite solar cells January 11th, 2019

Media invited to open meeting on the future of quantum technology held at RIT Jan. 23-25: Leaders from NASA, NSF, NIST and Sandia National Laboratory to attend January 11th, 2019

Nanotubes/Buckyballs/Fullerenes/Nanorods

Drilling speed increased by 20% – yet another upgrade in the oil & gas sector made possible by graphene nanotubes January 15th, 2019

Chemical synthesis of nanotubes: Nanometer-sized tubes made from simple benzene molecules January 11th, 2019

'Smart skin' simplifies spotting strain in structures: Rice U. invention can use fluorescing carbon nanotubes to reveal stress in aircraft, structures November 15th, 2018

Ultrasensitive toxic gas detector October 31st, 2018

Nanomedicine

Chirality in 'real-time' January 14th, 2019

Ultra-sensitive sensor with gold nanoparticle array January 9th, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases January 7th, 2019

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia January 7th, 2019

Sensors

Ultra-sensitive sensor with gold nanoparticle array January 9th, 2019

Study on low noise, high-performance transistors may bring innovations in electronics December 28th, 2018

Emerging trends in advanced nano-materials based electrochemical geno-sensors December 28th, 2018

Oxford Instruments participates in the launch of the European Quantum Technology Flagship Programme ‘QMiCS’ December 13th, 2018

Announcements

Drilling speed increased by 20% – yet another upgrade in the oil & gas sector made possible by graphene nanotubes January 15th, 2019

Chirality in 'real-time' January 14th, 2019

Spintronics 'miracle material' put to the test: Physicists build devices using mineral perovskite January 11th, 2019

Cartilage could be key to safe 'structural batteries' January 11th, 2019

Patents/IP/Tech Transfer/Licensing

New composite advances lignin as a renewable 3D printing material December 28th, 2018

Study on low noise, high-performance transistors may bring innovations in electronics December 28th, 2018

Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen October 31st, 2018

180 Degree Capital Corp. Announces New Portfolio Holdings – Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

New-Contracts/Sales/Customers

AdTech Photonics, a supplier of Quantum Cascade and other Infrared lasers has chosen Oxford Instruments etch system for its manufacturing facility October 26th, 2018

Iranian Firm Offering Nano-Products on Chinese Market October 16th, 2018

Nanometrics Delivers 100th: Atlas III System for Advanced Process Control Metrology Atlas III: Systems are qualified and in production for advanced devices in DRAM, 3D-NAND and Foundry/Logic August 2nd, 2018

Picosun’s ALD solutions make quality watches tick July 26th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project